NCT05434533View on ClinicalTrials.gov

The Prophylactic Role of Tranexamic Acid in High Risk Pregnant Women Undergoing Elective Cesarean Section in Prevention of Postpartum Hemorrhage

PHASE4CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

July 3, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

February 10, 2023

Conditions
High Risk Pregnant Women Undergoing Elective Cesarean Section
Interventions
DRUG

Tranexamic acid (Kapron, Amoun Pharmaceuticals SAE, Egypt. 5ml Amp, 100mg /1ml)

IV 1gm

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER